Brain Pericytes in Neurodegeneration

cell

Brain Pericytes in Neurodegeneration

Overview

flowchart TD
    Brain["Brain"] -->|"regulates"| Intestinal_Fat_Absorption["Intestinal Fat Absorption"]
    Brain["Brain"] -->|"mediates"| Gut["Gut"]
    Brain["Brain"] -->|"modulates"| Fat_Absorption["Fat Absorption"]
    brain["brain"] -->|"interacts with"| bone["bone"]
    Thyroid_Hormone_Transport["Thyroid Hormone Transport"] -->|"involved in"| Brain["Brain"]
    Senescent_Myeloid_Cells["Senescent Myeloid Cells"] -->|"associated with"| Brain["Brain"]
    APOE["APOE"] -->|"expressed in"| brain["brain"]
    KL["KL"] -->|"expressed in"| Brain["Brain"]
    Gut_Microbiome["Gut Microbiome"] -->|"interacts with"| Brain["Brain"]
    microglia["microglia"] -->|"expressed in"| brain["brain"]
    THYROID_HORMONE["THYROID HORMONE"] -->|"regulates"| BRAIN["BRAIN"]
    Thyroid_Hormone["Thyroid Hormone"] -->|"transports"| Brain["Brain"]
    TAU["TAU"] -->|"expressed in"| Brain["Brain"]
    Misfolded_Prions["Misfolded Prions"] -->|"expressed in"| Brain["Brain"]
    style brain fill:#4fc3f7,stroke:#333,color:#000

<table class=“infobox infobox-cell”> <tr> <th class=“infobox-header” colspan=“2”>Brain Pericytes in Neurodegeneration</th> </tr> <tr> <td class=“label”>Marker</td> <td>Expression</td> </tr> <tr> <td class=“label”>PDGFR-beta</td> <td>High</td> </tr> <tr> <td class=“label”>NG2 (CSPG4)</td> <td>High</td> </tr> <tr> <td class=“label”>CD146/MCAM</td> <td>Moderate</td> </tr> <tr> <td class=“label”>RGS5</td> <td>Moderate</td> </tr> <tr> <td class=“label”>alpha-SMA</td> <td>Variable</td> </tr> </table>

Brain pericytes are specialized mural cells embedded within the basement membrane of cerebral microvasculature, strategically positioned between endothelial cells and astrocytes[“@armulik2010”]. These cells constitute a critical component of the neurovascular unit, serving as the primary regulators of blood-brain barrier (BBB) integrity, cerebral blood flow, and neurovascular coupling[“@daneman2010”]. Pericytes are increasingly recognized as key players in neurodegenerative diseases, with pericyte degeneration documented in both Alzheimer’s disease (AD) and Parkinson’s disease (PD)[@nikolai2019][@blixt2022].

Pericytes differ from other vascular cells in several important ways. They have a distinctive morphology with multiple elongated processes that wrap around capillary endothelial cells, forming peg-and-socket junctions that allow direct cytoplasmic continuity[“@bell2010”]. This unique anatomical positioning enables pericytes to sense neural activity and respond by modulating capillary diameter, thereby coupling neuronal activity to local blood flow—a process known as neurovascular coupling[“@takano2014”].

Molecular Markers and Identification

Pericytes express several distinctive molecular markers that distinguish them from other cell types in the neurovascular unit:

The heterogeneity of pericyte populations has become increasingly apparent, with different pericyte subsets exhibiting distinct morphological and functional properties across brain regions[@sagare2013].

Role in the Blood-Brain Barrier

Structural Integrity

Pericytes are essential for maintaining BBB integrity through multiple mechanisms[@armulik2010]. During development, pericyte recruitment to nascent blood vessels is driven by platelet-derived growth factor B (PDGF-B) secretion from endothelial cells, and this recruitment is critical for BBB formation[@daneman2010]. Pericytes regulate endothelial tight junction formation and maintenance, controlling the paracellular transport pathway that prevents free passage of molecules between blood and brain.

Transport Regulation

Pericytes express numerous transporters and receptors that regulate transcellular passage of substances across the BBB[@zlokovic2011]. These include:

  • Glucose transporters (GLUT1)
  • Amino acid transporters
  • Lipoprotein receptors (LRP1)
  • Receptor for advanced glycation end products (RAGE)

Pericyte dysfunction leads to increased BBB permeability, allowing plasma proteins and potentially toxic metabolites to enter the brain parenchyma[@sengillo2013].

Pericyte Dysfunction in Alzheimer’s Disease

Evidence from Human Studies

Postmortem studies consistently reveal significant pericyte loss in AD brain tissue[@sengillo2013]. Quantitative analyses demonstrate a 30-60% reduction in pericyte coverage of cerebral capillaries in AD patients compared to age-matched controls[@blixt2022]. This loss correlates with the severity of cognitive impairment and is observed in regions particularly vulnerable to AD pathology, including the hippocampus and prefrontal cortex.

Mechanisms of Pericyte Degeneration

Multiple pathological processes contribute to pericyte loss in AD[@brown2024]:

  1. Amyloid-β accumulation: Aβ deposition directly damages pericytes through oxidative stress and inflammatory signaling. Aβ oligomers bind to RAGE on pericytes, triggering mitochondrial dysfunction and apoptosis.

  2. Tau pathology: Hyperphosphorylated tau in neuronal processes can physically damage pericyte-endothelial interactions, disrupting the neurovascular unit.

  3. Chronic hypoperfusion: Reduced cerebral blood flow creates a hypoxic environment that impairs pericyte function and survival.

  4. Neuroinflammation: Activated microglia release pro-inflammatory cytokines (IL-1β, TNF-α) that are toxic to pericytes.

Consequences for AD Pathogenesis

Pericyte dysfunction creates a vicious cycle that accelerates AD progression[@zlokovic2011]:

  1. Impaired neurovascular coupling reduces cerebral blood flow, leading to chronic hypoperfusion
  2. BBB breakdown allows toxic blood-derived proteins into the brain
  3. Reduced clearance of Aβ through the perivascular pathway
  4. Diminished metabolic support for neurons
  5. Enhanced neuroinflammation from peripheral immune cell entry

Pericyte Dysfunction in Parkinson’s Disease

While pericyte involvement in PD is less extensively studied than in AD, emerging evidence suggests similar mechanisms[@shiow2023]:

  • Postmortem studies show reduced pericyte coverage in PD substantia nigra
  • PD models demonstrate impaired neurovascular coupling in the basal ganglia
  • BBB permeability increases in PD, correlating with disease severity
  • Pericyte-derived PDGFR-β signaling may be disrupted in PD

Therapeutic Implications

Targeting Pericyte Function

Protecting or restoring pericyte function represents a promising therapeutic strategy for neurodegenerative diseases[@brown2024]:

  1. PDGF-B signaling agonists: Enhance pericyte recruitment and survival
  2. Antioxidants: Reduce oxidative stress-mediated pericyte damage
  3. Anti-inflammatory agents: Block cytokine-mediated pericyte toxicity
  4. RAGE antagonists: Prevent Aβ-induced pericyte damage

Vascular Cognitive Impairment

Pericyte dysfunction contributes to vascular cognitive impairment (VCI), often comorbid with AD. The combination of vascular and neurodegenerative pathology produces more severe cognitive deficits than either alone.

See Also

References

  1. Sagare et al., Pericyte-endothelial interactions (2013)
  2. Nikolai et al., Astrocyte and pericyte interactions (2019)
  3. Blixt et al., Loss of pericytes in aging and AD (2022)
  4. Brown et al., Pericyte dysfunction in neurodegenerative diseases (2024)
  5. Zhang et al., Pericyte loss in AD (2023)
  6. Sengillo et al., Pericyte degeneration in AD (2013)
  7. Shiow et al., Pericyte dysfunction in PD (2023)
  8. Armulik et al., Pericytes regulate the BBB (2010)
  9. Daneman et al., Pericytes required for BBB (2010)
  10. Bell et al., Pericytes control neurovascular functions (2010)
  11. Takano et al., Pericyte regulation of cerebral blood flow (2014)
  12. Hill et al., Emerging roles of pericytes in neurodegeneration (2014)
  13. Winkler et al., Pericytes in AD (2011)
  14. Zlokovic, Neurovascular pathways in AD (2011)
  15. Stark et al., Pericyte remodeling after stroke (2022)

Related Hypotheses

From the SciDEX Exchange — scored by multi-agent debate

Related Analyses:

Pathway Diagram

The following diagram shows the key molecular relationships involving Brain Pericytes in Neurodegeneration discovered through SciDEX knowledge graph analysis:

graph TD
    microglia["microglia"] -->|"expressed in"| brain["brain"]
    APOE["APOE"] -->|"expressed in"| brain["brain"]
    TDP_43["TDP-43"] -->|"expressed in"| brain["brain"]
    intranasal_administration["intranasal administration"] -->|"targets"| brain["brain"]
    detergent_insoluble_proteome["detergent-insoluble proteome"] -->|"expressed in"| brain["brain"]
    phenylalanine["phenylalanine"] -.->|"inhibits"| brain["brain"]
    GABRD["GABRD"] -->|"expressed in"| brain["brain"]
    IL_6["IL-6"] -->|"expressed in"| brain["brain"]
    autophagy["autophagy"] -->|"expressed in"| brain["brain"]
    AMPK["AMPK"] -->|"expressed in"| brain["brain"]
    PPARGC1A["PPARGC1A"] -->|"expressed in"| brain["brain"]
    Amyotrophic_lateral_sclerosis["Amyotrophic lateral sclerosis"] -->|"associated with"| brain["brain"]
    gut_microbiota["gut microbiota"] -->|"interacts with"| brain["brain"]
    designer_exosomes["designer exosomes"] -->|"expressed in"| brain["brain"]
    AAV_capsid_variants["AAV capsid variants"] -->|"therapeutic target"| brain["brain"]
    style microglia fill:#80deea,stroke:#333,color:#000
    style brain fill:#b39ddb,stroke:#333,color:#000
    style APOE fill:#4fc3f7,stroke:#333,color:#000
    style TDP_43 fill:#4fc3f7,stroke:#333,color:#000
    style intranasal_administration fill:#4fc3f7,stroke:#333,color:#000
    style detergent_insoluble_proteome fill:#4fc3f7,stroke:#333,color:#000
    style phenylalanine fill:#ff8a65,stroke:#333,color:#000
    style GABRD fill:#ce93d8,stroke:#333,color:#000
    style IL_6 fill:#4fc3f7,stroke:#333,color:#000
    style autophagy fill:#4fc3f7,stroke:#333,color:#000
    style AMPK fill:#4fc3f7,stroke:#333,color:#000
    style PPARGC1A fill:#4fc3f7,stroke:#333,color:#000
    style Amyotrophic_lateral_sclerosis fill:#ef5350,stroke:#333,color:#000
    style gut_microbiota fill:#80deea,stroke:#333,color:#000
    style designer_exosomes fill:#ff8a65,stroke:#333,color:#000
    style AAV_capsid_variants fill:#ff8a65,stroke:#333,color:#000

Sister wikis (recently updated · no domain on this page)

Recent activity here

No recent events touching this page.